Influence of prostaglandin analogues on epithelial cell proliferation and xenograft growth.
The influence of two prostaglandin (PG) analogues, 16,16-dimethyl PG E2 and 16,16-dimethyl PG F2 alpha and of the cyclo-oxygenase inhibitor, flurbiprofen, on epithelial cell proliferation was assessed using a stathmokinetic technique. The epithelia examined were those of the jejunal crypts, the colonic crypts and that of dimethylhydrazine-induced adenocarcinomas of rat colon. The influence of the two prostaglandin analogues, and of flurbiprofen, on the growth of a human colorectal tumour propagated as xenografts in immune-deprived mice was also assessed. The PG E2 analogue transiently inhibited xenograft growth, but was without effect on the mitotic rate in the rat tissues. The PG F2 alpha analogue was also found to inhibit xenograft growth but, unlike the PG E2 analogue, it was found to be a strong inhibitor of cell proliferation in rat colonic tumours, and an accelerator of proliferation in jejunal-crypt cells. The only statistically significant effect of flurbiprofen was to accelerate cell division in the rat colonic tumours.
D000230:Adenocarcinoma / Q000473:pathology*; D000818:Animals; D003110:Colonic Neoplasms / Q000473:pathology*; D004848:Epithelium / Q000473:pathology; D005260:Female; D005480:Flurbiprofen / Q000494:pharmacology; D006801:Humans; D007422:Intestines / Q000473:pathology; D008297:Male; D051379:Mice; D008938:Mitosis / Q000187:drug effects*; D009368:Neoplasm Transplantation; D009374:Neoplasms, Experimental / Q000188:drug therapy* / Q000473:pathology; D011459:Prostaglandins E, Synthetic / Q000494:pharmacology* / Q000627:therapeutic use; D011461:Prostaglandins F, Synthetic / Q000494:pharmacology* / Q000627:therapeutic use; D051381:Rats; D014183:Transplantation, Heterologous
D011459:Prostaglandins E, Synthetic; D011461:Prostaglandins F, Synthetic; D005480:Flurbiprofen